RPL10 and familial pancreatic carcinoma: When RPL10 was knocked-down in PANC-1 and MIA PaCa-2 cells, the expression of OSGIN1 indeed markedly increased, whereas HMOX1 showed little change in both cells (Fig. 3B), indicating that RPL10 is possible to regulate ROS level in pancreatic cancer cells.